Long-term hormone replacement therapy (HRT) reduces a woman's risk of developing osteoporosis, especially among women who have increased risk factors for osteoporosis. For more information, see the topic Osteoporosis.
After menopause, bones lose mass and density more rapidly than before menopause. Postmenopausal women are more likely to experience broken bones, such as hip fractures and compression fractures of the spinal bones. Women who have osteoporosis lose height because of bone loss.1
Osteoporosis is a common cause of bone fractures in older women, which can lead to chronic pain and disability. Fractures can affect:1
Estrogen replacement therapy (ERT) and hormone replacement therapy (HRT):
But HRT and ERT may increase the risk of health problems for some women, including blood clots, stroke and breast cancer.2
Discuss your long-term risk of osteoporosis with your doctor. Other medicines are available to prevent or treat osteoporosis related to menopause.
Citations
- Speroff L, Fritz MA (2005). Menopause and the perimenopausal transition. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 621–688. Philadelphia: Lippincott Williams and Wilkins.
- North American Menopause Society (2010). Estrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause Society. Menopause, 17(2): 242–255. Also available online: http://www.menopause.org/PSht10.pdf.
Last Revised: May 13, 2011
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.